N,N'-(iminodiethylene)bismyristamide(93918-46-8)
- Name: N,N'-(iminodiethylene)bismyristamide
- Synonyms:N,N’-(iminodiethylene)bismyristamide
- Molecular Formula:C32H65 N3 O2
- Molecular Weight:523.8774
- CAS Registry Number:93918-46-8
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.93918-46-8 N,N'-(iminodiethylene)bismyristamide
Assay:99% Appearance:powder or liquid Package:according to customer requirements Storage:store in dry dark and ventilated place Transportation:By Sea/Air/Courier Application:It is an important raw material.
Min. Order:10Gram
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)]
CAS No.93918-46-8 N,N'-(iminodiethylene)bismyristamide
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)]
CAS No.93918-46-8 Tetradecanamide,N,N'-(iminodi-2,1-ethanediyl)bis- (9CI)
Assay:99% Appearance:White powder Package:25KGS/Drum Storage:Room temperature Transportation:BY SEA Application:API锛孭harmaceutical intermediates
Min. Order:1Gram
Supplier:HENAN NEW BLUE CHEMICAL CO.,LTD [
China (Mainland)]
CAS No.93918-46-8 N,N'-(iminodiethylene)bismyristamide
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:N,N'-(iminodiethylene)bismyristamide
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)]

Other Product
- 64642-50-8/5,8,11-tris(3-tert-butoxy-3-oxopropyl)-3,6,9-trioxo-1-phenyl-2-oxa-4,7,10-triazadodecan-12-oic acid (non-preferred name)
- 81547-13-9/N-methyl[1,2,4]triazino[6,5-c]quinolin-2-amine
- 14282-76-9/2-Bromo-3-methylthiophene
- 17641-11-1/4-[(iodoacetyl)amino]phenyl iodoacetate
- 82560-79-0/ethyl N-{[{[(2,2-dimethyl-2,3-dihydro-1-benzofuran-7-yl)oxy]carbonyl}(methyl)amino]sulfanyl}-N-[(4-methylphenyl)sulfonyl]glycinate
- 43037-46-3/sodium p-[3-(p-chlorophenyl)-4,5-dihydro-1H-pyrazol-1-yl]benzenesulphinate
- 73130-48-0/1-methyl-3-[(2S)-1-methyl-5-oxopyrrolidin-2-yl]pyridinium
- 7505-30-8/benzene-1,3,5-triol; 1-ethylsulfanyl-N-phenyl-methanimidamide
- 25288-50-0/2-(2,3-dichlorophenoxy)-N-(pyridin-3-yl)acetamide
- 95262-50-3/Urs-12-en-28-oic acid,2-(acetyloxy)-3,19,23-trihydroxy-, b-D-glucopyranosyl ester, (2a,3b,4a)- (9CI)
- 66068-90-4/(S)-bis[[[2-(hydroxyphenyl)-1-methyl]ethyl]ammonium] [R-(R*,R*)]-tartrate
- 20805-90-7/13-ethyl-17-hydroxy-17-(prop-2-en-1-yl)-1,2,6,7,8,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthren-3-one (non-preferred name)
- 5411-23-4/2-(2-methylpyrrolidin-1-yl)ethyl 4-(propan-2-yloxy)benzoate
- 3983-06-0/3-propylcyclohexene
- 955-54-4/2-(4-CHLOROPHENYLTHIO)NICOTINIC ACID
- 703-61-7/2,4-DICHLOROQUINOLINE
- 136466-02-9/Tryptophan,N2-[[[(1S)-1-carboxy-3-methylbutyl]amino]carbonyl]-L-lysyl-L-alanyl-L-leucyl-N-methyl-L-leucyl-2-bromo-5-hydroxy-,cyclic (5®16)-peptide (9CI)
- 6153-55-5/3-(phenylamino)-1-(2,6,6-trimethylcyclohex-2-en-1-yl)butan-1-one
- 2345-01-9/ethyl N-(3-fluoro-2-methylphenyl)glycinate
- 93918-46-8/N,N'-(iminodiethylene)bismyristamide
- 212757-09-0/TRANS-2-(4-BROMOBENZOYL)-1-CYCLOHEXANE-CARBOXYLIC ACID, 98
- 31951-11-8/N-(3-nitro-4-tert-butyl-phenyl)acetamide
- 57341-46-5/N,N-bis(2-chloroethyl)-1,2,3,4-tetrahydro-1,3,2-benzodiazaphosphinin-2-amine 2-oxide
- 64107-58-0/2-[(2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl)amino]-5-(1,3-thiazol-2-ylmethyl)pyrimidin-4(3H)-one trihydrochloride
- 10248-58-5/2,4,6,8,9,10-Hexaoxa-1,3,5,7-tetraphosphatricyclo[3.3.1.13,7]decane
- 68649-14-9/Ethene, homopolymer,oxidized, calcium lithium salt
- 70474-55-4/6,7-dimethoxy-1-(thiophen-3-ylmethyl)-1,2,3,4-tetrahydroisoquinoline
- 7773-83-3/1-DODECANETHIOL
- 126722-26-7/3H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-11,14-dione,4-ethenyl-3-(b-D-glucopyranosyloxy)-4,4a,5,5a,6,12-hexahydro-,(3S,4R,4aS,5aS)- (9CI)
- 7047-71-4/2-Chromanvaleric acid,6-hydroxy-a,2,5,7,8-pentamethyl-, methylester, acetate, (S)- (8CI)